key: cord-0917856-v2w54ede
authors: Pani, Arianna; Inglese, Elvira; Puoti, Massimo; Cento, Valeria; Alteri, Claudia; Romandini, Alessandra; Di Ruscio, Federica; Senatore, Michele; Moreno, Mauro; Tarsia, Paolo; Colombo, Fabrizio; Epis, Oscar Massimiliano; Panetta, Valentina; Vismara, Chiara; Bellone, Andrea; Scaglione, Francesco
title: Sex differences in electrolyte imbalances caused by SARS‐CoV‐2: A cross‐sectional study
date: 2021-10-06
journal: Int J Clin Pract
DOI: 10.1111/ijcp.14882
sha: e2e07eb1af33aa61618a7b07037026dbacf7d80b
doc_id: 917856
cord_uid: v2w54ede

BACKGROUND: Since SARS‐CoV‐2 spread, evidence regarding sex differences in progression and prognosis of COVID‐19 have emerged. Besides this, studies on patients' clinical characteristics have described electrolyte imbalances as one of the recurrent features of COVID‐19. METHODS: We performed a cross‐sectional study on all patients admitted to the emergency department (ED) from 1 March to 31 May 2020 who had undergone a blood gas analysis and a nasopharyngeal swab test for SARS‐CoV‐2 by rtPCR. We defined positive patients as cases (n = 710) and negatives as controls (n = 619), for a total number of patients of 1.329. The study was approved by the local ethics committee Area 3 Milan. Data were automatically extracted from the hospital laboratory SQL‐based repository in anonymised form. We considered as outcomes potassium (K(+)), sodium (Na(+)), chlorine (Cl(−)) and calcium (Ca(++)) as continuous and as categorical variables, in their relation with age, sex and SARS‐CoV‐2 infection status. RESULTS: We observed a higher prevalence of hypokalaemia among patients positive for SARS‐CoV‐2 (13.7% vs 6% of negative subjects). Positive patients had a higher probability to be admitted to the ED with hypokalaemia (OR 2.75, 95% CI 1.8‐4.1, P < .0001) and women were twice as likely to be affected than men (OR 2.43, 95% CI 1.67‐3.54, P < .001). Odds ratios for positive patients to manifest with an alteration in serum Na(+) was (OR 1.6, 95% CI 1.17‐2.35, P < .001) and serum chlorine (OR 1.6, 95% CI 1.03‐2.69, P < .001). Notably, OR for positive patients to be hypocalcaemic was 7.2 (95% CI 4.8‐10.6, P < .0001) with a low probability for women to be hypocalcaemic (OR 0.63, 95% CI 0.4‐0.8, P = .005). CONCLUSIONS: SARS‐CoV‐2 infection is associated with a higher prevalence of hypokalaemia, hypocalcaemia, hypochloraemia and sodium alterations. Hypokalaemia is more frequent among women and hypocalcaemia among men.

Since December 2019 the world has been struggling to fight the novel coronavirus SARS-CoV-2. As soon as the virus spread in China, researchers noticed the higher predisposition of men to contract COVID-19. 1, 2 Evidence that emerged subsequently also revealed an association between male sex and more severe disease and death. 3, 4 Some authors have attributed the reasons for these differences to sex differences in immune response, 5 to differences in the prevalence of smoking subjects among men and women 6 and to genetics. 7 Few studies have investigated the impact of sex differences in clinical manifestations of the disease other than disease severity and mortality. 8 Early studies on COVID-19 have highlighted the association between the disease and sodium (Na + ), potassium (K + ), calcium (Ca ++ ) and chloride (Cl − ) abnormalities. 1,9, 10 Chen et al 11 described a high prevalence of hypokalaemic subjects among patients hospitalised with COVID-19. Furthermore, the severity of the disease was associated with a higher degree of hypokalaemia. Authors have also shown, in a small sample of patients, that hypokalaemic subjects had a higher mean urinary K + output than non-hypokalaemic patients, suggesting a possible implication for increased K + urine loss.

This mechanism could be explained by the disruption caused by the binding of SARS-CoV-2 to angiotensin-converting enzyme 2 (ACE2) with a possible impact on the renin-angiotensin system (RAS).

Despite the aforementioned evidence, little is still known regarding electrolyte disturbances in COVID-19 and in SARS-CoV-2 infection.

The aim of this study was to examine the prevalence of electrolyte imbalances among patients with SARS-CoV-2 infection in a large cohort and its distribution according to age and sex.

The study protocol was approved by the Ethics Committee Area 3 Milano (prot. 92-15032020). Signed informed content was obtained for each participant. This study was conducted in accordance with This cross-sectional study has been performed at the ASST GOM Niguarda Hospital in Italy, in which there are all medical specialties both for adult and children. It is a regional reference for Lombardy and national for Italy for transplants, some rare diseases, heart diseases, for time-dependent diseases, major traumas and emergencies.

During the pandemic, it was chosen as a hub to face the hospitalisation needs of COVID-19 positive patients and to manage the regional vaccination plan. The Lombardy Region has modified the hospital network by creating sixteen hubs that respond to specific non-COVID-19 emergencies. Thanks to this, we can distinguish and exclude patients with previous diseases that could influence evaluated study outcomes.

In fact, in this study, the transferred patients to other hubs for the management of trauma, cardiological and/or vascular surgery emergencies, were excluded from the controls, as well as patients with chronical liver disease or eating disorders that was managed by outpatient departments outside the hospital.

At the ASST GOM Niguarda hospital, we store all analytical results of the tests performed in the laboratory in an SQL-based repository.

With the purpose to conduct this study, a query was created to extract data with no personal information other than gender and date of birth. This query extracted laboratory results based on the date of execution, the requesting department and the type of service performed. Derived data supporting the findings of this study are available from the corresponding author on request.

The fields extracted were: patient's ID (a numeric string that uniquely identifies the patient without personal data), sex, birth date day of lab tests execution (with a truncation for the extracted data referred to the period 1 March to 31 May), tests ID, tests results and hospital ward.

In this way we, were able to collect the biochemical and microbiological profile of patients at admittance to the emergency department (ED) and categorise patients based on their positivity (or negativity) to SARS-CoV-2, sex and age.

We considered a cohort of patients admitted to the ED from 1

March to 31 May 2020 and screened for SARS-CoV-2 infection with fever, desaturation, or symptoms attributable to infection. As 

• We observed a higher prevalence of hypokalaemia in patients positive for SARS-CoV-2, and women were twice as likely to be affected than men.

• Positive patients also had a higher prevalence of hypocalcaemia, hypochloraemia and sodium alteration.

Hypokalaemia appears to be more frequent among women and hypocalcaemia among men.

patients were for the first time observed and detailed.

Niguarda is a COVID-19-hub, a good percentage of patients with COVID-19 symptoms were diverted to our hospital. This allowed us to have access to a good population useful for our study and to exclude patients with other chronical interfering pathologies managed by other institutes. Inclusion criteria were: age over 18 years and the performance, during the permanence in the Emergency Department, of at least one blood gas analysis (both arterial and venous) performed using POC Siemens RAPIDPoint 500 Blood Gas System. Compared with central Laboratory analyzers, results obtained from POC Siemens RAPIDPoint 500 blood gas system are stackable for all tested parameters taken into consideration in this study. These results are warranted for our own procedures and devices. 12 We collected data regarding electrolyte profile, pH, blood glucose, white blood cell counts, lymphocyte counts, neutrophils and creatinine.

Exclusion criteria were: patients who were admitted to specialist wards (ie, for diagnosis of cardiological diseases, liver disease or major trauma). Therefore, only those patients who have been kept for non-specialist observation are considered controls. 

As outcomes, we considered potassium (K + ), sodium (Na + ), chloride (Cl − ) and calcium (Ca ++ ) both as continuous and as categorical variables, in their relationship with age, sex and SARS-CoV-2 infection status. We defined imbalances of K + , Na + , Cl − and Ca ++ , according to ranges presented in Table S1 .

Leveraging the fact that a blood gas analysis was performed on the majority of patients accepted to the ED, we decided to consider the electrolyte values deriving from this analysis, to avoid potential bias because of the comparison of different methods.

We analysed potential effect modifiers such as renal disease, by calculating the estimated Glomerular Filtration Rate (eGFR) using and for this, to describe outcomes we use the terms of the "Human Phenotype Ontology" (HPO) to better promote the link between SARS-CoV2 to their phenotypes in support of infectious disease research.

Patients characteristics were summarised with mean and standard The test results were pre-processed using k-means before applying clustering and generating the heatmap and the dendrogram. All test results were transformed for the analysis in Z-score intensity signal. Z-score is constructed by taking the ratio of weighted mean difference and combined standard deviation according to Box and Tiao (1992) . 15 The application of a classical method of data normalisation, z-score transformation, provides a way of standardising data across a wide range of experiments 

We analysed the distribution of serum K + values as a continuous Further analyses of the population according to sex and class of age (Table 2 ) allowed us to observe a higher prevalence of hypokalaemic patients among women positive for SARS-CoV2. The prevalence was similar for all classes of age. The difference between positive and negative patients was statistically significant for men below 65 years (P = .013), women below 65 years (P < .001). In women, over 75 years it was possible to note a difference that did not reach statistical significance (P = .069).

At binary logistic regression, the OR for patients with SARS-CoV-2 to present with hypokalaemia at admission to the ED is twice than the one for non-infected patients (Table 3) . At multivariable logistic regression, adjusting for age and sex, the probability to be admitted to the ED with hypokalaemia was nearly three times higher for patients with SARS-CoV-2 infection (OR 2.75, 95% CI 1.8-4.1, P < .001) (Figure 3 ).

For women, the probability to be admitted to the ED with hypokalaemia, adjusting for SARS-CoV-2 positivity and age, is more than twice than the one for men (OR 2.43, 95% CI 1.67-3.54, P < .001) (Figure 3) .

Not abnormal kalaemia The intensity of the red color highlights the classes of patients in which the prevalence of subjects with potassium imbalances is higher. 

Regarding natraemia, we observed a higher prevalence of both patients with hyperrnatraemia and hyponatraemia among positive subjects (Table A in Supporting Information) . Women tended to be more hypernatraemic while men were more hyponatraemic. However, these differences among groups were not statistically significant (Table B in Supporting Information). At logistic regression, patients with SARS-CoV-2 infection had a slightly higher probability to present to the ER with an alteration in natraemia (OR 1.6, 95% CI 1.17-2.35, P < .001).

We detected also a mild tendency of infected patients to present with hypochloraemia ( At binary logistic regression, the OR for being hypocalcaemic if positive to SARS-CoV-2 was 7.2 (95% CI 4.8-10.6, P < .0001) and

at multivariable logistic regression women had a lower probability to have hypocalcaemia (OR 0.63, 95% CI 0.4-0.8 P = .005) ( Figure 3 ).

In this cohort study, we evaluated the association between electrolyte imbalances and SARS-CoV-2 infection, deepening its distribution women. This is supported by the influence of female sex hormones, mainly oestrogens, on ACE2 which are able to impact the ACE/ACE2 activity ratio and the expression of angiotensin 1-7, 16, 17 also according to age. 18 Regarding calcium we observed a reverse trend, with a higher prevalence of hypocalcaemia among male patients; a trend is also observed in the non-positive population but exacerbated by SARS-CoV-2 infection. As reported elsewhere, 19 sex differences in hypocalcaemia could be correlated to the more frequent use of vitamin D and/or calcium among women for osteoporosis prevention. 20 From a pathophysiological perspective, SARS-CoV-2 is able to penetrate human cells by binding to ACE2 through a receptorbinding domain present on the spike glycoprotein. 21 ACE2 is a receptor implied in the RAS system, in particular in the modulation of renal sodium transporters, 22,23 especially the Na + /K + ATPase on the baso-lateral membrane of epithelial tubular cells. 24, 25 As explained in Figure 4 , ACE2 cleaves angiotensin II in angiotensin 1-7, which is able to exert a natriuretic function by acting on the AT1 receptor. Furthermore, the action of ACE2 is also important to the vasodilation triggered by Ca ++ release from the endoplasmic reticulum induced by angiotensin 1-7. The disruption of this pathway caused by the binding of SARS-CoV-2 on ACE2 could underlie the electrolytes alterations observed in this study and others as well. 1, 9, 10, 11 Indeed, recent studies reported evidence of kidney damage manifesting as tubular dysfunction and necrosis, endothelial alterations and deposition of complement complex on tubules. 26, 27 Electrolyte imbalances, especially of potassium and calcium, associated with SARS-CoV-2 infection could also help explain the numerous reports of QT prolongations, arrhythmias and cardiac deaths reported in patients with COVID-19 [28] [29] [30] and ascribed to treatments with macrolides and hydroxychloroquine. 31, 32 This highlights the importance to continuously monitor and manage hypokalaemia and electrolytes imbalances 33, 34 The limitations of this study lie in its retrospective nature and in the non-correlation of lab values with disease severity and clinical outcomes. Besides this, we believe that our findings are important to better understand the pathophysiology of COVID-19 disease, and especially sex differences in the manifestation of the disease which certainly impact on better prognosis for women. Romandini, contributed to data analysis and interpretation, paper drafting, and gave critical revision. Mauro Moreno contributed to data interpretation, paper drafting, and gave critical revision for intellectual content. Francesco Scaglione gave critical revision for intellectual content.

The manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.

All authors declare no conflict of interests.

Data available in article supplementary material. The data that supports the findings of this study are available in the supplementary material of this article.

Clinical characteristics of coronavirus disease 2019 in China

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a singlecentered, retrospective, observational study

Impact of sex and gender on COVID-19 outcomes in Europe

Factors associated with COVID-19-related death using OpenSAFELY

Sex differences in immune responses that underlie COVID-19 disease outcomes

Impact of Tobacco Smoking on the risk of COVID-19.A large scale retrospective cohort study

ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy

Features of severe COVID-19: a systematic review and meta-analysis

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series

Assessment of hypokalemia and clinical characteristics in patients with coronavirus disease

Point-of-care versus central laboratory measurements of hemoglobin, hematocrit, glucose, bicarbonate and electrolytes: a prospective observational study in critically Ill patients

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

linking human pathogens to their phenotypes in support of infectious disease research

Bayesian inference in statistical analysis. chapter 11 transformations and other topics

Enhanced renal immunocytochemical expression of ANG-(1-7) and ACE2 during pregnancy

Tissue-specific regulation of ACE/ACE2 and AT1/AT2 receptor gene expression by oestrogen in apolipoprotein E/oestrogen receptor-alpha knock-out mice

Sex differences in the aging pattern of renin-angiotensin system serum peptidases

Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing?

Fracture risk assessment in postmenopausal women referred to an Italian center for osteoporosis: a single day experience in Messina. Clin Cases Miner Bone Metab

Structural basis of receptor recognition by SARS-CoV-2

Angiotensin-(1-7): an update

Renal actions of angiotensin-(1-7)

Angiotensin-(1-7) modulates the ouabain-insensitive Na + -ATPase activity from basolateral membrane of the proximal tubule

Angiotensin-(1-7) reverts the stimulatory effect of angiotensin II on the proximal tubule Na(+)-ATPase activity via a A779-sensitive receptor

Autopsy findings in COVID-19-related deaths: a literature review

SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule

QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin

QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: a systematic review

Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York state

Castrejon-Castrejon S. COVID-19 and QT interval prolongation: more than just drug toxicity?

Macrolides and viral infections: focus on azithromycin in COVID-19 pathology

The European Society for Cardiology. ESC guidance for the diagnosis and management of CV disease during the COVID-19 pandemic

Effect of combination therapy of hydroxychloroquine and azithromycin on mortality in patients with COVID-19